Einträge von Reck, Martin auf dem Publikationsserver

Lee, Siow Ming, Schulz, Christian, Prabhash, Kumar, Kowalski, Dariusz, Szczesna, Aleksandra, Han, Baohui, Rittmeyer, Achim, Talbot, Toby, Vicente, David, Califano, Raffaele, Cortinovis, Diego, Le, Anh Tuan, Huang, Dingzhi, Liu, Geoffrey, Cappuzzo, Federico, Reyes Contreras, Jessica, Reck, Martin, Palmero, Ramon, Mak, Milena Perez, Hu, Youyou, Morris, Stefanie, Höglander, Elen, Connors, Mary, Biggane, Alice M, Vollan, Hans Kristian und Peters, Solange (2023) First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study. The Lancet 402 (10400), S. 451-463. Volltext nicht vorhanden.

Christopoulos, Petros , Kluck, Klaus, Kirchner, Martina, Lüders, Heike, Roeper, Julia, Falkenstern-Ge, Roger-Fei, Szewczyk, Marlen, Sticht, Florian, Saalfeld, Felix C. , Wesseler, Claas , Hackanson, Björn, Dintner, Sebastian, Faehling, Martin, Kuon, Jonas, Janning, Melanie, Kauffmann-Guerrero, Diego, Kazdal, Daniel, Kurz, Sylke, Eichhorn, Florian, Bozorgmehr, Farastuk, Shah, Rajiv , Tufman, Amanda, Wermke, Martin, Loges, Sonja, Brueckl, Wolfgang M., Schulz, Christian, Misch, Daniel, Frost, Nikolaj , Kollmeier, Jens , Reck, Martin, Griesinger, Frank, Grohé, Christian, Hong, Jin-Liern, Lin, Huamao M., Budczies, Jan , Stenzinger, Albrecht und Thomas, Michael (2022) The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions. European Journal of Cancer 170, S. 106-118. Volltext nicht vorhanden.